Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Other financing activities: 2018-2024

Historic Other financing activities for EyePoint Pharmaceuticals (EYPT) over the last 7 years, with Dec 2024 value amounting to -$4.5 million.

  • EyePoint Pharmaceuticals' Other financing activities rose 140.59% to $615,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.3 million, marking a year-over-year increase of 88.34%. This contributed to the annual value of -$4.5 million for FY2024, which is 1100.44% down from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Other financing activities of -$4.5 million as of FY2024, which was down 1,100.44% from $451,000 recorded in FY2023.
  • EyePoint Pharmaceuticals' Other financing activities' 5-year high stood at $451,000 during FY2023, with a 5-year trough of -$4.5 million in FY2024.
  • In the last 3 years, EyePoint Pharmaceuticals' Other financing activities had a median value of -$295,000 in 2022 and averaged -$1.5 million.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Other financing activities surged by 252.88% in 2023 and then tumbled by 1,100.44% in 2024.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Other financing activities stood at -$90,000 in 2020, then tumbled by 66.67% to -$150,000 in 2021, then crashed by 96.67% to -$295,000 in 2022, then skyrocketed by 252.88% to $451,000 in 2023, then plummeted by 1,100.44% to -$4.5 million in 2024.